Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121650 · ClinicalTrials.gov registry record
Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 54
- Enrollment target
NCT04121650: Completed study, sponsored by Massachusetts General Hospital.
NCT04121650 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04121650 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
In this project, the investigators will extend prior results of parent-reported executive function growth and symptom reduction in children receiving home-based treatment with the Collaborative Problem Solving treatment approach (CPS), with a particular focus on examining children who have attention deficit hyperactivity disorder (ADHD). The investigators will examine executive functioning (EF) of children who are receiving CPS, measuring EF with parent-report and objective computer-based tasks, at two timepoints: at the start of treatment and approximately four months later, and will collect symptoms at these plus three additional timepoints: at discharge, 6-months after discharge, and 12-months after discharge.
Primary Outcome
Strengths and Difficulties Questionnaire (Parent-report measuring child emotional problems, conduct issues, hyperactivity/inattention, peer relationship problems, and pro- social behavior)
Interventions
- BEHAVIORAL Collaborative Problem Solving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2022-07-01 |
What the finished NCT04121650 record still lists
NCT04121650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Collaborative Problem Solving is the first listed.
NCT04121650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04121650 about?
NCT04121650 is a clinical study titled "Executive Function and Symptom Reduction in Youth Receiving Home-based Treatment With Collaborative Problem Solving". In this project, the investigators will extend prior results of parent-reported executive function growth and symptom reduction in children receiving home-based treatment with the Collaborative Problem Solving treatment approach (CPS), with a particular focus on examining children who have attention...
What is the current status of trial NCT04121650?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2019-10-14. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04121650?
The interventions under investigation include: Collaborative Problem Solving (BEHAVIORAL).
Who is sponsoring clinical trial NCT04121650?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI